Recent policy changes impact ‘cardiometabolic care cascade’

PHILADELPHIA — Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that expand access and lower drug costs will be key to reducing the burden of disease in the U.S., a speaker said.At the Heart in Diabetes CME Conference, Rishi K. Wadhera, MD, MPP, MPhil, cardiologist at Beth Israel Deaconess Medical Center, discussed gaps in the

Raccontata dahealio.com